Tandem Diabetes Care [TNDM] vs Abbott Laboratories [ABT] Detailed Stock Comparison

Tandem Diabetes Care

NASDAQ

Abbott Laboratories

NYSE

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Tandem Diabetes Care wins in 5 metrics, Abbott Laboratories wins in 13 metrics, with 0 ties. Abbott Laboratories appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric	Tandem Diabetes Care	Abbott Laboratories	Better
P/E Ratio (TTM)	-7.27	16.53	Tandem Diabetes Care
Price-to-Book Ratio	5.52	4.53	Abbott Laboratories
Debt-to-Equity Ratio	340.56	26.50	Abbott Laboratories
PEG Ratio	-0.11	0.45	Tandem Diabetes Care
EV/EBITDA	-11.52	20.59	Tandem Diabetes Care
Profit Margin (TTM)	-20.51%	32.43%	Abbott Laboratories
Operating Margin (TTM)	-13.24%	19.73%	Abbott Laboratories
EBITDA Margin (TTM)	N/A	19.73%	N/A
Return on Equity	-111.92%	30.93%	Abbott Laboratories
Return on Assets (TTM)	-6.41%	6.62%	Abbott Laboratories
Free Cash Flow (TTM)	$4.99M	$6.35B	Abbott Laboratories
Dividend Yield	N/A	1.28%	N/A
1-Year Return	-75.22%	17.14%	Abbott Laboratories
Price-to-Sales Ratio (TTM)	0.73	5.32	Tandem Diabetes Care
Enterprise Value	$874.38M	$235.76B	Abbott Laboratories
EV/Revenue Ratio	0.87	5.47	Tandem Diabetes Care
Gross Profit Margin (TTM)	52.29%	56.44%	Abbott Laboratories
Revenue per Share (TTM)	$15	$25	Abbott Laboratories
Earnings per Share (Diluted)	$-3.08	$7.97	Abbott Laboratories
Beta (Stock Volatility)	1.47	0.71	Abbott Laboratories

Performance

Key Stats

Valuation

Financials

Short Interest

Dividends

Tandem Diabetes Care vs Abbott Laboratories Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock	1D	1W	1M	3M	6M	YTD
Tandem Diabetes Care	7.92%	3.66%	-24.47%	-48.96%	-64.35%	-69.17%
Abbott Laboratories	0.45%	2.10%	6.09%	-0.79%	-2.16%	16.36%

Long-term Returns

Stock	1Y	3Y	5Y	10Y	15Y	20Y
Tandem Diabetes Care	-75.22%	-76.33%	-90.22%	-90.56%	-94.94%	-94.94%
Abbott Laboratories	17.14%	29.54%	19.14%	186.83%	452.07%	515.10%

Performance Comparison

This comparison requires JavaScript for dynamic charts and real-time data. For complete performance analysis, visit the individual stock overview pages:

Tandem Diabetes Care (TNDM): View Full Stock Overview

Abbott Laboratories (ABT): View Full Stock Overview

The individual stock overview pages contain detailed performance metrics, historical charts, financial data, and comparison tools that work without JavaScript.

Key Performance Metrics Available:

Daily, weekly, monthly, and yearly returns
52-week high and low prices
Market capitalization and valuation ratios
Financial health and profitability metrics
Dividend history and yield information

Performance & Financial Health Analysis: Tandem Diabetes Care vs Abbott Laboratories

Metric	TNDM	ABT
Market Information
Market Cap i	$735.83M	$229.31B
Market Cap Category	Small cap	Mega cap
10 Day Avg. Volume i	3,752,020	6,185,250
90 Day Avg. Volume i	2,384,093	7,383,993
Last Close	$11.93	$132.60
52 Week Range	$9.98 - $47.60	$110.86 - $141.23
% from 52W High	-74.95%	-6.11%
All-Time High	$302.50 (Jan 13, 2014)	$142.60 (Dec 27, 2021)
% from All-Time High	-96.06%	-7.01%
Growth Metrics
Quarterly Revenue Growth	0.09%	0.07%
Quarterly Earnings Growth	N/A	0.37%
Financial Health
Profit Margin (TTM) i	-0.21%	0.32%
Operating Margin (TTM) i	-0.13%	0.20%
Return on Equity (TTM) i	-1.12%	0.31%
Debt to Equity (MRQ) i	340.56	26.50
Cash & Liquidity
Book Value per Share (MRQ)	$1.97	$29.05
Cash per Share (MRQ)	$4.67	$4.18
Operating Cash Flow (TTM) i	$9.72M	$9.04B
Levered Free Cash Flow (TTM) i	$31.96M	$5.92B
Dividends
Last 12-Month Dividend Yield i	N/A	1.28%
Last 12-Month Dividend i	N/A	$1.69

Valuation & Enterprise Metrics Analysis: Tandem Diabetes Care vs Abbott Laboratories

Metric	TNDM	ABT
Price Ratios
P/E Ratio (TTM) i	-7.27	16.53
Forward P/E i	-9.00	25.53
PEG Ratio i	-0.11	0.45
Price to Sales (TTM) i	0.73	5.32
Price to Book (MRQ) i	5.52	4.53
Market Capitalization
Market Capitalization i	$735.83M	$229.31B
Enterprise Value i	$874.38M	$235.76B
Enterprise Value Metrics
Enterprise to Revenue i	0.87	5.47
Enterprise to EBITDA i	-11.52	20.59
Risk & Other Metrics
Beta i	1.47	0.71
Book Value per Share (MRQ) i	$1.97	$29.05

Financial Statements Comparison: Tandem Diabetes Care vs Abbott Laboratories

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)	TNDM	ABT
Revenue/Sales i	$234.42M	$10.36B
Cost of Goods Sold i	$116.02M	$4.47B
Gross Profit i	$118.41M	$5.89B
Research & Development i	$125.43M	$716.00M
Operating Income (EBIT) i	$-120.88M	$1.69B
EBITDA i	$-116.42M	$2.66B
Pre-Tax Income i	$-122.09M	$1.78B
Income Tax i	$8.47M	$453.00M
Net Income (Profit) i	$-130.56M	$1.33B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)	TNDM	ABT
Cash & Equivalents i	$53.57M	$6.53B
Total Current Assets i	$663.44M	$23.15B
Total Current Liabilities i	$288.18M	$13.00B
Long-Term Debt i	$431.75M	$12.74B
Total Shareholders Equity i	$155.29M	$49.06B
Retained Earnings i	$-1.18B	$47.72B
Property, Plant & Equipment i	$79.22M	N/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)	TNDM	ABT
Operating Cash Flow i	$-6.71M	$1.42B
Capital Expenditures i	$-6.21M	$-484.00M
Free Cash Flow i	$-15.70M	$933.00M
Debt Repayment i	$-40.76M	$-1.00B
Common Stock Repurchase i	N/A	$-280.00M

Short Interest & Institutional Ownership Analysis

Metric	TNDM	ABT
Shares Short i	8.75M	18.33M
Short Ratio i	4.75	2.44
Short % of Float i	0.18%	0.01%
Average Daily Volume (10 Day) i	3,752,020	6,185,250
Average Daily Volume (90 Day) i	2,384,093	7,383,993
Shares Outstanding i	66.26M	1.73B
Float Shares i	61.84M	1.73B
% Held by Insiders i	0.01%	0.01%
% Held by Institutions i	1.21%	0.81%

Dividend Analysis & Yield Comparison: Tandem Diabetes Care vs Abbott Laboratories

Metric	TNDM	ABT
Last 12-Month Dividend i	N/A	$1.69
Last 12-Month Dividend Yield i	N/A	1.28%
3-Year Avg Annual Dividend i	N/A	$1.92
3-Year Avg Dividend Yield i	N/A	0.49%
3-Year Total Dividends i	N/A	$5.77
Ex-Dividend Date	N/A	Jan 15, 2025

Tandem Diabetes Care [TNDM] vs Abbott Laboratories [ABT] Detailed Stock Comparison